Eptifibatide
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00063 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | rheumatoid arthritis | KG + DL |
| 2 | sickle cell-hemoglobin d disease syndrome | KG + DL |
| 3 | hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | KG + DL |
| 4 | sickle cell-beta-thalassemia disease syndrome | KG + DL |
| 5 | sickle cell-hemoglobin c disease syndrome | KG + DL |
| 6 | sickle cell-hemoglobin E disease syndrome | KG + DL |
| 7 | hemoglobinopathy | KG + DL |
| 8 | female breast carcinoma | KG + DL |
| 9 | beta-thalassemia with other manifestations | KG + DL |
| 10 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 11 | pyropoikilocytosis, hereditary | KG + DL |
| 12 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 13 | brachydactyly-syndactyly syndrome | KG + DL |
| 14 | colobomatous microphthalmia-rhizomelic dysplasia syndrome | KG + DL |
| 15 | pyruvate kinase deficiency of red cells | KG + DL |
| 16 | sickle cell disease and related diseases | KG + DL |
| 17 | sickle cell anemia | KG + DL |
| 18 | hereditary persistence of fetal hemoglobin | KG + DL |
| 19 | gout | KG + DL |
| 20 | myocardial infarction | KG + DL |
| 21 | acquired monoclonal Ig light chain-associated Fanconi syndrome | KG + DL |
| 22 | sclerosing cholangitis | KG + DL |
| 23 | malignant mesothelioma (disease) | KG + DL |
| 24 | gastric linitis plastica | KG + DL |
| 25 | myelodysplastic syndrome | KG + DL |
| 26 | myocardial infarction (disease) | KG + DL |
| 27 | plasma cell myeloma | KG + DL |
| 28 | pleural adenomatoid tumor | KG + DL |
| 29 | unclassified myelodysplastic syndrome | KG + DL |
| 30 | partial deletion of the long arm of chromosome 5 | KG + DL |
| 31 | aregenerative anemia | KG + DL |
| 32 | refractory cytopenia of childhood | KG + DL |
| 33 | malignant peritoneal mesothelioma | KG + DL |
| 34 | endocarditis | KG + DL |
| 35 | severe congenital hypochromic anemia with ringed sideroblasts | KG + DL |
| 36 | pleural biphasic mesothelioma | KG + DL |
| 37 | chronic hepatitis B virus infection | KG + DL |
| 38 | autosomal dominant familial hematuria-retinal arteriolar tortuosity-contractures syndrome | KG + DL |
| 39 | pleural epithelioid mesothelioma | KG + DL |
| 40 | pleural mesothelioma | KG + DL |
| 41 | coronary stenosis | KG + DL |
| 42 | brain small vessel disease 1 with or without ocular anomalies | KG + DL |
| 43 | pericardium cancer | KG + DL |
| 44 | pleural sarcomatoid mesothelioma | KG + DL |
| 45 | lymphohistiocytoid mesothelioma | KG + DL |
| 46 | well differentiated papillary mesothelioma | KG + DL |
| 47 | IgG4-related retroperitoneal fibrosis | KG + DL |
| 48 | IgG4-related pachymeningitis | KG + DL |
| 49 | pneumocystosis | KG + DL |
| 50 | septal myocardial infarction | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.